Type II results from KCNJ1 gene mutation involving neonatal population with polyhydramnios, nephrocalcinosis, hypokalemic alkalosis, hyposthenuria, and transient hyperkalemia. This evidence concerns the gene KCNJ1 and Polyhydramnios.